SC Stays Hearings In HCs On Covid Vaccines, Issues Notices On Pleas Of “Manufacturers”

New Delhi : The Supreme Court on Thursday stayed the ongoing hearing related to COVID-19 vaccines in the Delhi and Bombay High Courts. It also sought responses from the Centre and others on pleas of the Serum Institute and Bharat Biotech seeking transfer of the cases from the high courts to the apex court.

A bench headed by Chief Justice, S A Bobde took note of the pleas of the two firms that the high courts are conducting parallel proceedings on vaccine related issues and they need to be transferred to the top court for an authoritative judgement.

The bench also transferred to itself the vaccine-related case going on in the Delhi High Court.

The vaccine manufacturing firms have said different high courts are seeking data on how many vaccines are produced and when they will give vaccines to all.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert